Efficacy and Safety of Angong Niuhuang Wan for Stroke
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of using Chinese Medicine Angong Niuhuang Wan in stroke
patients, the modified Rankin Scale (mRS) score will be used as primary outcome, the National
Institutes of Health Stroke Scale (NIHSS) score, The Modified Barthel Index (MBI) score and
the Montreal Cognitive Assessment (MoCA) scores will be used as secondary outcome measures.